4.2 Article

Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling

Journal

GLYCOCONJUGATE JOURNAL
Volume 29, Issue 5-6, Pages 365-377

Publisher

SPRINGER
DOI: 10.1007/s10719-012-9416-z

Keywords

beta-glucan; Grifola frondosa; Biological response modifier; Dectin-1

Funding

  1. New Drug Creation and Manufacturing Program [2012ZX09301001-003]
  2. National Science Fund for Distinguished Young Scholars [81125025]
  3. funds for Industry-University-Research Institution Alliance in Guangdong Province, China [2010A090200041]

Ask authors/readers for more resources

A soluble homogeneous beta-glucan, GFPBW1, with a molecular mass of 300 kDa was purified from the fraction of the fruit bodies of Grifola frondosa extracted with 5 % NaOH. Using various methods, such as infrared spectroscopy, NMR, methylation and monosaccharide composition analysis, its structure was determined to be a beta-D-(1-3)-linked glucan backbone with a single beta-D-(1-6)-linked glucopyranosyl residue branched at C-6 on every third residue. It induced TNF-alpha and IL-6 production and the activation of Syk and NF-kappa B signaling in resident peritoneal macrophages from ICR mice, which could be significantly inhibited by the blocking reagent laminarin. A competitive phagocytosis assay with FITC-zymosan indicated that GFPBW1 could bind to DC-associated C-type lectin 1 (Dectin-1). The TNF-alpha secretion and activation of Syk/NF-kappa B signaling triggered by GFPBW1 were enhanced in RAW264.7 cells overexpressing wild but not mutant (Delta 38 and Y15S) Dectin-1. Furthermore, GFPBW1 potentiated the Concanavalin A-induced proliferative response of splenocytes and inhibited Sarcoma-180 growth allografted in ICR mice but not in immunodeficient BALB/c nu/nu mice. These results suggested that the antitumor activity of GFPBW1 was partially associated with the activation of macrophages via the Dectin-1/Syk/NF-kappa B signaling pathway. This molecule could be a promising biological response modifier with clear application for antitumor therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available